Divis Laboratories Fact Sheet, Divis Laboratories Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Fact Sheet    (DIVI)


Check It Out: Are Small Caps the Best Way to Play the Massive EV Opportunity?


Here is the latest financial fact sheet of Divis Laboratories. For more details, see the Divis Laboratories quarterly results and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

DIVIS LABORATORIES Price History

Price Rs 4,783.3
Mkt Cap Rs m 1,269,803
Vol '000 35.6
P/E X 62.0
P/CF X 56.7
EPS (TTM) Rs 77.2
% ch % -3.1
No. of shares m 265.47
% ch week % -6.4
% ch 1-mth % -2.5
% ch 12-mth % 54.7
52 week H/L Rs 5,269.0/3,015.0
(As on Sep 28, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DIVIS LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
DIVIS LABORATORIES EQUITY SHARE DATA
High Rs1,3801,1421,7672,2583,913 
Low Rs6125339951,4671,824 
Sales per share (Unadj.) Rs151.5145.8186.3203.2262.5 
Earnings per share (Unadj.) Rs39.933.051.051.974.7 
Diluted earnings per shareRs39.933.051.051.974.7 
Cash flow per share (Unadj.) Rs44.638.457.358.984.4 
Dividends per share (Unadj.) Rs10.0010.0016.0016.0020.00 
Adj. dividends per shareRs10.0010.0016.0016.0020.00 
Avg Dividend yield %1.01.21.20.90.7 
Book value per share (Unadj.) Rs201.8223.2262.1275.4350.1 
Adj. book value per shareRs201.8223.2262.1275.4350.1 
Shares outstanding (eoy) m265.47265.47265.47265.47265.47 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x6.65.77.49.210.9 
Avg P/E ratio x24.925.327.135.938.4 
P/CF ratio (eoy) x22.321.824.131.634.0 
Price / Book Value ratio x4.93.85.36.88.2 
Dividend payout %25.030.331.430.926.8 
Avg Mkt Cap Rs m264,354222,310366,619494,429761,517 
No. of employees `000NANANANANA 
Total wages/salary Rs m4,9994,5615,4236,2118,258 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
DIVIS LABORATORIES INCOME DATA
Net Sales Rs m40,22438,70249,46353,94469,694 
Other income Rs m7491,1341,5561,896626 
Total revenues Rs m40,97339,83651,01955,84170,320 
Gross profit Rs m14,47112,62818,73018,23228,612 
Depreciation Rs m1,2331,4251,6891,8622,556 
Interest Rs m3424477121 
Profit before tax Rs m13,95312,31318,55118,19526,660 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m3,3493,5435,0234,4296,818 
Profit after tax Rs m10,6048,77013,52713,76519,843 
Gross profit margin %36.032.637.933.841.1 
Effective tax rate %24.028.827.124.325.6 
Net profit margin %26.422.727.325.528.5 
DIVIS LABORATORIES BALANCE SHEET DATA
Current assets Rs m40,10545,35146,50155,73567,906 
Current liabilities Rs m6,5956,5348,46818,20517,284 
Net working cap to sales %83.3100.376.969.672.6 
Current ratio x6.16.95.53.13.9 
Inventory Days Days2763382197610 
Debtors Days Days829686956878 
Net fixed assets Rs m34,18138,12041,45238,51545,963 
Share capital Rs m531531531531531 
"Free" reserves Rs m53,04358,71769,04172,56892,415 
Net worth Rs m53,57459,24869,57273,09992,946 
Long term debt Rs m00000 
Total assets Rs m74,28683,47187,95394,250113,869 
Interest coverage x416.3520.5397.4255.81,270.5 
Debt to equity ratio x00000 
Sales to assets ratio x0.50.50.60.60.6 
Return on assets %14.310.515.414.717.4 
Return on equity %19.814.819.418.821.3 
Return on capital %26.120.826.725.028.7 
Exports to sales %00000 
Imports to sales %25.521.924.621.50 
Exports (fob) Rs m00000 
Imports (cif) Rs m10,2608,48512,18711,5970 
Fx inflow Rs m35,38432,35941,23844,8320 
Fx outflow Rs m10,2739,04212,40511,8370 
Net fx Rs m25,11123,31728,83332,9960 
DIVIS LABORATORIES CASH FLOW
From Operations Rs m 11,504 7,759 9,543 12,159 19,469 
From Investments Rs m -11,396 -4,783 -6,854 -835 751 
From Financial Activity Rs m 24 -3,142 -2,459 -10,914 -349 
Net Cashflow Rs m 132 -166 230 411 19,872 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 52.0%
Institution 37.2%
Non-Institution 10.9%
Total 100.0%
Free Float 48.1%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF 1-72/23( P)/ Divis/303, Divi Towers Cyber Hills, Gachibowli, Hyderabad - 500032
E-MAIL mail@divislabs.com WEB www.divislabs.com
TEL 040 2378 6300 FAX 040 2378 6460
SECTOR PHARMACEUTICALS GROUP Divis Labs
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
AUDITOR P. V. R. K. Nageswara Rao & Co.
CHM: Murali K. Divi (MD) COMP SEC: P. V. Lakshmi Rajani YEAR OF INC: 1990 BSE CODE: 532488 FV (Rs): 2 DIV YIELD (%): 0.4

Read: DIVIS LABORATORIES 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ZOTA HEALTH CARE  TTK HEALTHCARE  PARMAX PHARMA  ASHRAM ONLINE  TORRENT PHARMA  

Compare DIVIS LABORATORIES With:   ZOTA HEALTH CARE  TTK HEALTHCARE  PARMAX PHARMA  ASHRAM ONLINE  TORRENT PHARMA  




Today's Market

Sensex Sheds 410 Points, Nifty Ends Below 17,750; Oil & Gas and Power Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended lower.

Views on news

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock (Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield (Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC (Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

Top Small Caps to Buy Now Views On News (Views On News)

Sep 18, 2021

Rahul Shah on why he would invest in these unusual 20 small cap stocks

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS